155 related articles for article (PubMed ID: 27076625)
21. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
22. TGF-β and EGF induced HLA-I downregulation is associated with epithelial-mesenchymal transition (EMT) through upregulation of snail in prostate cancer cells.
Chen XH; Liu ZC; Zhang G; Wei W; Wang XX; Wang H; Ke HP; Zhang F; Wang HS; Cai SH; Du J
Mol Immunol; 2015 May; 65(1):34-42. PubMed ID: 25618241
[TBL] [Abstract][Full Text] [Related]
23. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.
Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH
Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929
[TBL] [Abstract][Full Text] [Related]
24. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
[TBL] [Abstract][Full Text] [Related]
25. MUC1-C Oncoprotein Integrates a Program of EMT, Epigenetic Reprogramming and Immune Evasion in Human Carcinomas.
Rajabi H; Kufe D
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):117-122. PubMed ID: 28302417
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.
Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y
Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320
[TBL] [Abstract][Full Text] [Related]
27. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
[TBL] [Abstract][Full Text] [Related]
28. Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-κB signaling pathway.
Song J; Feng L; Zhong R; Xia Z; Zhang L; Cui L; Yan H; Jia X; Zhang Z
Mol Carcinog; 2017 Jan; 56(1):36-48. PubMed ID: 26859114
[TBL] [Abstract][Full Text] [Related]
29. Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome.
Tripathi SC; Peters HL; Taguchi A; Katayama H; Wang H; Momin A; Jolly MK; Celiktas M; Rodriguez-Canales J; Liu H; Behrens C; Wistuba II; Ben-Jacob E; Levine H; Molldrem JJ; Hanash SM; Ostrin EJ
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):E1555-64. PubMed ID: 26929325
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
31. ALX1 promotes migration and invasion of lung cancer cells through increasing snail expression.
Yao W; Liu Y; Zhang Z; Li G; Xu X; Zou K; Xu Y; Zou L
Int J Clin Exp Pathol; 2015; 8(10):12129-39. PubMed ID: 26722397
[TBL] [Abstract][Full Text] [Related]
32. Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.
Ye X; Weinberg RA
Trends Cell Biol; 2015 Nov; 25(11):675-686. PubMed ID: 26437589
[TBL] [Abstract][Full Text] [Related]
33. MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Su L; Luo Y; Yang Z; Yang J; Yao C; Cheng F; Shan J; Chen J; Li F; Liu L; Liu C; Xu Y; Jiang L; Guo D; Prieto J; Ávila MA; Shen J; Qian C
Cancer Res; 2016 Sep; 76(17):5054-67. PubMed ID: 27364559
[TBL] [Abstract][Full Text] [Related]
34. Benzophenone-3 increases metastasis potential in lung cancer cells via epithelial to mesenchymal transition.
Phiboonchaiyanan PP; Busaranon K; Ninsontia C; Chanvorachote P
Cell Biol Toxicol; 2017 Jun; 33(3):251-261. PubMed ID: 27796700
[TBL] [Abstract][Full Text] [Related]
35. Epithelial-mesenchymal transition: Initiation by cues from chronic inflammatory tumor microenvironment and termination by anti-inflammatory compounds and specialized pro-resolving lipids.
Lee CH
Biochem Pharmacol; 2018 Dec; 158():261-273. PubMed ID: 30389404
[TBL] [Abstract][Full Text] [Related]
36. Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1.
Cha BK; Kim YS; Hwang KE; Cho KH; Oh SH; Kim BR; Jun HY; Yoon KH; Jeong ET; Kim HR
Oncotarget; 2016 Aug; 7(35):57213-57227. PubMed ID: 27528025
[TBL] [Abstract][Full Text] [Related]
37. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Katsuno Y; Lamouille S; Derynck R
Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
[TBL] [Abstract][Full Text] [Related]
38. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
[TBL] [Abstract][Full Text] [Related]
39. SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell.
Liu H; Gu Y; Yin J; Zheng G; Wang C; Zhang Z; Deng M; Liu J; Jia X; He Z
Cell Signal; 2014 Dec; 26(12):2710-20. PubMed ID: 25152373
[TBL] [Abstract][Full Text] [Related]
40. Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
Xiao B; Liu H; Gu Z; Ji C
Arch Bronconeumol; 2016 Oct; 52(10):505-11. PubMed ID: 26858166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]